Mazurkiewicz, M.; Bodnar, P.; Blachut, D.; Chwalba, T.; Wagner, W.; Barczyk, E.; Romuk, E.; Jacheć, W.; Wojciechowska, C.
Adipokines and Adipose Tissue: The Role and Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients with Diabetes or Heart Failure. Biomedicines 2025, 13, 1098.
https://doi.org/10.3390/biomedicines13051098
AMA Style
Mazurkiewicz M, Bodnar P, Blachut D, Chwalba T, Wagner W, Barczyk E, Romuk E, Jacheć W, Wojciechowska C.
Adipokines and Adipose Tissue: The Role and Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients with Diabetes or Heart Failure. Biomedicines. 2025; 13(5):1098.
https://doi.org/10.3390/biomedicines13051098
Chicago/Turabian Style
Mazurkiewicz, Michalina, Patryk Bodnar, Dominika Blachut, Tomasz Chwalba, Wiktor Wagner, Eliza Barczyk, Ewa Romuk, Wojciech Jacheć, and Celina Wojciechowska.
2025. "Adipokines and Adipose Tissue: The Role and Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients with Diabetes or Heart Failure" Biomedicines 13, no. 5: 1098.
https://doi.org/10.3390/biomedicines13051098
APA Style
Mazurkiewicz, M., Bodnar, P., Blachut, D., Chwalba, T., Wagner, W., Barczyk, E., Romuk, E., Jacheć, W., & Wojciechowska, C.
(2025). Adipokines and Adipose Tissue: The Role and Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients with Diabetes or Heart Failure. Biomedicines, 13(5), 1098.
https://doi.org/10.3390/biomedicines13051098
